https://www.prokarium.com/privacy https://www.prokarium.com/cookie https://www.prokarium.com/news https://www.prokarium.com/events https://www.prokarium.com/news/prokarium-to-present-at-the-american-urology-association-(aua)-annual-meeting https://www.prokarium.com/news/prokarium-to-present-at-lsx-world-congress https://www.prokarium.com/news/prokarium-presents-data-at-eau-2026 https://www.prokarium.com/news/prokarium-to-attend-bio-europe-spring-2026 https://www.prokarium.com/news/prokarium-to-present-at-nextgen-biomed-2026 https://www.prokarium.com/news/prokarium-to-present-at-the-annual-european-association-of-urology-(eau)-congress https://www.prokarium.com/news/prokarium-announces-upcoming-oral-presentations-of-interim-clinical-data-at-the-eau-and-aua-2026-annual-meetings https://www.prokarium.com/news/prokarium-to-attend-the-io360%C2%B0-summit https://www.prokarium.com/news/prokarium%E2%80%99s-ceo-ibs-mahmood-cso-livija-deban-and-coo-dara-henry-will-be-attending-the-44th-annual-j.p.-morgan-healthcare-conference-san-francisco-california-12-15-january-2026. https://www.prokarium.com/news/prokarium%E2%80%99s-cso-livija-deban-will-be-attending-the-io360%C2%B0-summit-in-boston-ma-10-12th-february-2026. https://www.prokarium.com/news/prokarium-appoints-ibs-mahmood-as-chief-executive-officer https://www.prokarium.com/news/prokarium-to-attend-london-life-sciences-week-2025 https://www.prokarium.com/news/prokarium-to-present-at-elrig%E2%80%99s-uk-forum-2025 https://www.prokarium.com/news/prokarium-to-attend-bio-europe-2025 https://www.prokarium.com/news/prokarium-to-present-at-sitc-annual-meeting-2025 https://www.prokarium.com/news/prokarium-to-attend-techbio-uk https://www.prokarium.com/news/prokarium-to-attend-bio-2025 https://www.prokarium.com/news/prokarium-is-attending-the-american-urological-association-(aua)-annual-meeting-2025 https://www.prokarium.com/news/prokarium-is-presenting-at-the-american-association-for-cancer-research-(aacr)-annual-meeting-2025 https://www.prokarium.com/news/prokarium-is-speaking-at-executive-insights-2025 https://www.prokarium.com/news/prokarium-is-speaking-at-biotrinity-2025 https://www.prokarium.com/news/prokarium-to-attend-io360-summit https://www.prokarium.com/news/prokarium-to-attend-bio-europe-spring https://www.prokarium.com/news/prokarium-to-present-at-nextgen-biomed-2025 https://www.prokarium.com/news/prokarium-to-present-at-9th-annual-microbiome-movement-summit https://www.prokarium.com/news/prokarium-to-attend-jpm-2025 https://www.prokarium.com/news/prokarium-to-present-at-sitc-2024 https://www.prokarium.com/news/prokarium-expands-ip-portfolio-with-two-new-u.s.-patents-strengthening-its-position-in-bladder-cancer https://www.prokarium.com/news/prokarium-to-attend-bio-europe-2024 https://www.prokarium.com/news/prokarium-to-attend-biojapan-2024 https://www.prokarium.com/news/prokarium-to-attend-esmo-congress-2024 https://www.prokarium.com/news/prokarium-to-present-at-seed-2024 https://www.prokarium.com/news/prokarium-to-attend-bio-international-convention-2024 https://www.prokarium.com/news/prokarium-to-present-at-the-21st-cimt-annual-meeting-in-mainz https://www.prokarium.com/news/prokarium-to-attend-swiss-biotech-day https://www.prokarium.com/news/prokarium-to-speak-at-oecd-%E2%80%93-ocde https://www.prokarium.com/news/prokarium-secures-ukri-grant-to-fund-development-of-living-cures-platform https://www.prokarium.com/news/prokarium-to-attend-bio-europe-spring-conference https://www.prokarium.com/news/prokarium-to-attend-cowen-44th-annual-health-care-conference https://www.prokarium.com/news/prokarium-to-attend-10th-annual-io360-conference https://www.prokarium.com/news/prokarium-achieves-milestone-with-first-patient-dosing-in-paradigm-1-non-muscle-invasive-bladder-cancer-clinical-trial https://www.prokarium.com/news/prokarium-to-attend-j.p.-morgan-2024-healthcare-conference https://www.prokarium.com/news/prokarium-to-attend-jeffries-2023-london-healthcare-conference https://www.prokarium.com/news/prokarium-to-present-at-lsx-investival-showcase https://www.prokarium.com/news/prokarium-to-attend-bio-europe-2023 https://www.prokarium.com/news/prokarium-to-present-at-the-society-for-immunotherapy-of-cancer-2 https://www.prokarium.com/news/prokarium-to-present-at-the-society-for-immunotherapy-of-cancer https://www.prokarium.com/news/prokarium-achieves-major-milestone-with-fda%E2%80%99s-ind-approval-for-bladder-cancer-program https://www.prokarium.com/news/prokarium-to-speak-at-bioventure-nexus https://www.prokarium.com/news/prokarium-to-present-at-the-biocentury-bayhelix-east-west-summit https://www.prokarium.com/news/prokarium-to-present-poster-the-seventh-international-cancer-immunotherapy-conferenceprokarium-(cicon23) https://www.prokarium.com/news/prokarium-to-attend-the-23rd-annual-biotech-in-europe-forum-on-20-21-september-2023 https://www.prokarium.com/news/prokarium-to-present-poster-at-synbiobeta-on-23-25-may-2023 https://www.prokarium.com/news/prokarium-to-speak-at-ginkgo-bioworks%E2%80%99-annual-ferment-conference-on-may-19-2023-in-boston https://www.prokarium.com/news/prokarium-to-attend-the-9th-lsx-world-congress-on-3-4-may-2023-in-london https://www.prokarium.com/news/prokarium-announces-30-million-financing-to-deliver-lead-program-into-clinic-and-build-novel-therapeutic-platform https://www.prokarium.com/news/prokarium-to-speak-and-present-at-sachs-on-march-1-2-2023-in-zurich https://www.prokarium.com/news/prokarium-to-attend-the-2023-bio-ceo-investor-conference-in-new-york-february-6-9-2023 https://www.prokarium.com/news/prokarium-to-attend-the-9th-immuno-oncology-360%C2%B0-(io360%C2%B0)-conference-in-new-york-february-7-10-2023 https://www.prokarium.com/news/prokarium-to-speak-at-the-biomarkers-uk-conference-in-manchester-february-27-28-2023 https://www.prokarium.com/news/prokarium-and-ginkgo-bioworks-announce-partnership-to-discover-multiple-targets-for-rna-therapeutics-and-immuno-oncology https://www.prokarium.com/news/prokarium-to-attend-13th-annual-jefferies-london-healthcare-conference https://www.prokarium.com/news/prokarium-to-present-at-society-for-immunotherapy-of-cancer-(sitc)-37th-annual-meeting https://www.prokarium.com/news/prokarium-to-present-at-the-tumour-microenvironment-conference-in-berlin-november-1-2-2022 https://www.prokarium.com/news/prokarium-to-attend-bio-europe-in-leipzig-october-24-26-2022 https://www.prokarium.com/news/prokarium-strengthens-manufacturing-capabilities-with-appointment-of-peter-juul-madsen-as-vice-president-of-cmc https://www.prokarium.com/news/prokarium-to-participate-at-the-techbiouk-organised-by-the-bioindustry-association https://www.prokarium.com/news/prokarium-to-chair-a-session-at-immuno-uk-on-september-30-2022-in-london https://www.prokarium.com/news/prokarium-to-present-at-the-6th-international-cancer-immunotherapy-conference-(cicon) https://www.prokarium.com/news/prokarium-to-present-at-the-22nd-annual-biotech-in-europe-forum-by-sachs-in-basel https://www.prokarium.com/news/prokarium-to-attend-lsx-conference-in-london-may-10-11 https://www.prokarium.com/news/prokarium-exercises-option-for-an-exclusive-worldwide-license-for-the-use-of-salmonella-immunotherapy-in-the-treatment-of-bladder-cancer https://www.prokarium.com/news/prokarium-expands-r-d-capabilities-with-london-biofoundry-to-deepen-microbial-immunotherapy-pipeline https://www.prokarium.com/news/prokarium-shares-preclinical-proof-of-concept-data-on-its-microbial-immunotherapy-bladder-cancer-program-at-sitc-2021 https://www.prokarium.com/news/prokarium-promotes-livija-deban-to-chief-scientific-officer-to-drive-pipeline-expansion-in-cancer-immunotherapy https://www.prokarium.com/news/prokarium-and-wacker-biotech-sign-manufacturing-contract-for-prokarium%E2%80%99s-microbial-immunotherapy-for-bladder-cancer-patients https://www.prokarium.com/news/prokarium-appoints-industry-veteran-thomas-eldered-as-chairman-of-the-board https://www.prokarium.com/news/prokarium-appoints-kristen-albright-as-chief-executive-officer https://www.prokarium.com/news/prokarium-gains-the-cover-of-the-international-journal-of-molecular-science-with-the-latest-entervax-publication https://www.prokarium.com/news/prokarium-closes-21m-series-b-financing-round-and-strengthens-board https://www.prokarium.com/news/prokarium-obtains-notice-of-allowance-for-us-patent-covering-the-modification-of-an-attenuated-strain-of-salmonella-enterica-serovar-typhi-to-develop-a-vaccine-against-enteric-fever https://www.prokarium.com/news/prokarium-signs-an-exclusive-option-agreement-with-the-lausanne-university-hospital-(centre-hospitalier-universitaire-vaudois-%E2%80%93-chuv)-for-the-treatment-of-non-muscle-invasive-bladder-cancer-(nmibc) https://www.prokarium.com/news/prokarium-appoints-new-advisors-to-increase-oncology-expertise https://www.prokarium.com/news/prokarium-announces-mhra-acceptance-to-run-a-phase-i-trial-with-its-lead-vaccine-candidate-entervax%E2%84%A2 https://www.prokarium.com/news/prokarium-secures-%C2%A34.6m-from-wellcome-to-fund-the-clinical-development-of-its-lead-vaccine-programme https://www.prokarium.com/news/prokarium-starts-2019-with-move-to-the-london-bioscience-innovation-centre https://www.prokarium.com/news/prokarium-expands-its-team-to-develop-oncology-programmes-appointing-livija-deban-as-vice-president-immunology-and-oncology-and-kristen-albright-as-vice-president-bd-and-translational-research https://www.prokarium.com/news/prokarium-secures-10-million-investment-from-saudi-swedish-and-korean-investors-for-clinical-development-of-revolutionary-thermostable-vaccines